Abstract: Disclosed is an electrode assembly, a battery, and a battery pack and a vehicle including the same. In the electrode assembly, a first electrode, a second electrode, and a separator interposed therebetween are wound based on an axis to define a core and an outer circumference. The first electrode includes an uncoated portion at a long side end thereof and exposed out of the separator along a winding axis direction of the electrode assembly. A part of the uncoated portion is bent in a radial direction of the electrode assembly to form a bending surface region that includes overlapping layers of the uncoated portion, and in a partial region of the bending surface region, the number of stacked layers of the uncoated portion is 10 or more in the winding axis direction of the electrode assembly.

Abstract: The present invention relates to a method and system for providing language learning services. The method of providing language learning services, according to the present invention, the method may include: activating, in response to receiving an input for acquiring a learning target image through a user terminal, a camera of the user terminal; specifying at least a portion of an image taken by the camera as the learning target image; receiving language learning information for the learning target image from a server; providing the language learning information to the user terminal; and storing, based on a request for storing of the language learning information, the language learning information in association with the learning target image, such that the learning target image is used in conjunction with learning of the language learning information.

Abstract: An inkjet head unit capable of performing high-resolution pixel printing on a large-size substrate and a substrate treatment apparatus including the inkjet head unit are provided. The substrate treatment apparatus includes: a processing unit supporting and moving a substrate; an inkjet head unit performing pixel printing on the substrate; and a gantry unit moving the inkjet head unit over the substrate, wherein the inkjet head unit includes head packs, which include a plurality of nozzles ejecting a substrate treatment liquid onto the substrate, and a head base, in which the head packs are installed and the head packs are disposed in a single row in the head base.

Abstract: Memory array structures, and methods of their formation, might include a first memory cell having a first control gate and an adjacent first portion of a charge-blocking structure, a second memory cell having a second control gate and an adjacent second portion of the charge-blocking structure, and a first dielectric material between the first control gate and the second control gate, and adjacent to a third portion of the charge-blocking structure that is between the first and second portions of the charge-blocking structure. The third portion of the charge-blocking structure might include a second dielectric material and a third dielectric material different than the second dielectric material, and the first portion of the charge-blocking structure and the second portion of the charge-blocking structure might each include the third dielectric material and a fourth dielectric material different than the second dielectric material. Apparatus might include such memory array structures.

Abstract: An electrohydraulic microjet drug delivery device includes: a discharge body provided with a power supply unit in which electric energy is stored; and a medicinal fluid delivery body detachably attached to the discharge body, the medicinal fluid delivery body including a pressure generation unit configured to store a pressure generation liquid, a medicinal fluid storage unit configured to store a medicinal fluid, an elastic separation membrane installed between the pressure generation unit and the medicinal fluid storage unit and configured to separate the pressure generation liquid and the medicinal fluid, a discharger installed inside the pressure generation unit so as to be submerged in the pressure generation liquid and configured to generate a spark using the electric energy stored in the power supply unit, and a nozzle kept in communication with the medicinal fluid storage unit.

Abstract: A strainer for a fuel pump according to the present invention includes: a communicating pipe including a flow path formed to communicate with a fuel inlet of the fuel pump; a filter including an internal space in which a fuel flows and coupled to the communicating pipe so that the internal space communicates with the communicating pipe; and a rib disposed in the filter and coupled to the communicating pipe, in which the filter includes a first filtering portion extending in a length direction with respect to the communicating pipe, a connecting portion extending in a width direction at an edge of the first filtering portion, and a second filtering portion extending in the length direction at the connecting portion and spaced apart from the first filtering portion in the width direction. Therefore, the strainer may have a relatively large filtering area and a small size.

Abstract: A strainer for a fuel pump according to the present invention includes: a communicating pipe including a flow path formed to communicate with a fuel inlet of the fuel pump; a filter including an internal space in which a fuel flows and coupled to the communicating pipe so that the internal space communicates with the communicating pipe; and a rib disposed in the filter and coupled to the communicating pipe, in which the filter includes a first filtering portion extending in a length direction with respect to the communicating pipe, a connecting portion extending in a width direction at an edge of the first filtering portion, and a second filtering portion extending in the length direction at the connecting portion and spaced apart from the first filtering portion in the width direction. Therefore, the strainer may have a relatively large filtering area and a small size.

Abstract: An electrohydraulic microjet drug delivery device includes: a discharge body provided with a power supply unit in which electric energy is stored; and a medicinal fluid delivery body detachably attached to the discharge body, the medicinal fluid delivery body including a pressure generation unit configured to store a pressure generation liquid, a medicinal fluid storage unit configured to store a medicinal fluid, an elastic separation membrane installed between the pressure generation unit and the medicinal fluid storage unit and configured to separate the pressure generation liquid and the medicinal fluid, a discharger installed inside the pressure generation unit so as to be submerged in the pressure generation liquid and configured to generate a spark using the electric energy stored in the power supply unit, and a nozzle kept in communication with the medicinal fluid storage unit, wherein when the spark is generated in the discharger, a part of the pressure generation liquid is vaporized and expanded to d

Abstract: Provided are a method of recognizing an emotion of a driver and an apparatus using the same. The method includes receiving emotion recognition information including at least one of vehicle state information and driver emotion state information, determining whether a dominant emotion state exists among one or more emotion states possessed by the driver on the basis of the emotion recognition information and an emotion recognition model, and performing a reaction inducing interaction with respect to the driver determined on the basis of the determined dominant emotion state together with the driver when the dominant emotion state of the driver is determined to exist.

Abstract: A digital cockpit system communicates with a cloud server and outputs an output result of a vehicle's internal system according to a human-machine interface (HMI) output policy optimized for a personal driving tendency of a personal driver by using a driver-customized parameter received from the cloud server.

Abstract: The present invention relates to a parenteral composition for maintaining the efficacy of a filler for a long time, containing a collagen hydrolysate as an active ingredient. The composition, according to the present invention, can maintain the efficacy of a hyaluronic acid filler for a longer time, thereby enabling the effect thereof to be maintained irrespective of a smaller frequency of filler operations, and thus there is an advantage of also reducing skin irritation. In addition, there is an advantage of enabling an immediate effect since an administration method is simple as a parenteral administration and enables direct penetration into the skin.

Abstract: Disclosed is a nozzle device and a minimally invasive injection device, and the nozzle device for a minimally invasive injection device according to an exemplary embodiment includes an outlet to generate a microjet of a liquid, and an injection part of a micro-scale size connected to the outlet and adapted to be inserted into a skin tissue to a preset depth.

Abstract: The present invention relates to a parenteral composition for maintaining the efficacy of a filler for a long time, containing a collagen hydrolysate as an active ingredient. The composition, according to the present invention, can maintain the efficacy of a hyaluronic acid filler for a longer time, thereby enabling the effect thereof to be maintained irrespective of a smaller frequency of filler operations, and thus there is an advantage of also reducing skin irritation. In addition, there is an advantage of enabling an immediate effect since an administration method is simple as a parenteral administration and enables direct penetration into the skin.

Abstract: The disclosed compounds have antiviral activity against C-type virus, an optical isomer thereof, a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient for preventing or treating liver disease caused by hepatitis C virus. The benzidine derivative according to the present invention has excellent antiviral activity against hepatitis C virus and exhibits excellent medicinal activity in the living body, and thus the pharmaceutical composition containing the same as an active ingredient can be useful as a pharmaceutical composition for preventing or treating liver disease, such as acute hepatitis C, chronic hepatitis C, cirrhosis, or hepatocellular carcinoma, caused by C-type virus.

Abstract: The present invention relates to a composition for maintaining efficacy of a filler for a long period of time by containing collagen as an active ingredient. The composition according to the present invention is useful since the composition can promote the synthesis of hyaluronic acid and inhibit activity of hyaluronidase, thereby maintaining the efficacy of a hyaluronic acid filler for a longer period of time. Therefore, even with less number of times of filler injection, the efficacy of the filler can be maintained and skin irritation can be also reduced.

Abstract: A multi-hop relay maritime communication apparatus installed in a ship is disclosed. The maritime communication apparatus includes a first access module configured to comprise a plurality of directional antennas integrally formed; a second access module configured to comprise an omni-directional antenna; and a bridge configured to be connected to the first access module and the second access module via an Ethernet interface.

Abstract: A multi-hop relay maritime communication apparatus installed in a ship is disclosed. The maritime communication apparatus includes a first access module configured to comprise a plurality of directional antennas integrally formed; a second access module configured to comprise an omni-directional antenna; and a bridge configured to be connected to the first access module and the second access module via an Ethernet interface.

Abstract: The present invention relates to an apparatus and method of performing wireless communication using multiple directional antennas. The transportation means according to the present invention includes at least two communication devices, wherein one of the at least two communication devices, communication device A, includes a directional antenna group 1, and the other communication device, communication device B, includes a directional antenna group 2, and wherein the communication device A performs directional antenna selection control of the directional antenna group 1 included in the communication device A depending on whether the communication device B is connected with a network. According to the present invention, one of the communication devices gains access to a satellite station, a base station, or other ships, at least one antenna of another communication device may be used to relay wireless communication and may play a role as a base station or an AP.

Abstract: Disclosed herein are a maritime communication apparatus and method. The maritime communication apparatus includes a land-based network communication unit, a maritime network communication unit, and a communication control unit. The land-based network communication unit communicates with a land-based communication network. The maritime network communication unit communicates with a maritime communication network. The communication control unit links the communication of the land-based network communication unit with the communication of the maritime network communication unit in accordance with a destination address of data provided by any one of the land-based network communication unit and the maritime network communication unit.

Abstract: The disclosed compounds have antiviral activity against C-type virus, an optical isomer thereof, a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient for preventing or treating liver disease caused by hepatitis C virus. The benzidine derivative according to the present invention has excellent antiviral activity against hepatitis C virus and exhibits excellent medicinal activity in the living body, and thus the pharmaceutical composition containing the same as an active ingredient can be useful as a pharmaceutical composition for preventing or treating liver disease, such as acute hepatitis C, chronic hepatitis C, cirrhosis, or hepatocellular carcinoma, caused by C-type virus.